{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:15:22Z","timestamp":1788246922288,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clae.2026.102647","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:57:00Z","timestamp":1774411020000},"page":"102647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing hyaluronic acid therapy for dry eye disease: a systematic review, meta-analysis, and meta-regression by concentration and comparator type"],"prefix":"10.1016","volume":"49","author":[{"given":"Clara","family":"Martinez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2026.102647_b0005","unstructured":"Klingenberg HO. Excipient update: a real eye-opener: advances in hyaluronic acid for ophthalmology. Available from: https:\/\/drug-dev.com\/excipient-update-a-real-eye-opener-advances-in-hyaluronic-acid-for-ophthalmology\/; 2013 [accessed 14 June 2025]."},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/OPX.0000000000000100","article-title":"Comparative studies of hyaluronan in marketed ophthalmic products","volume":"91","author":"Liu","year":"2014","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/ICL.0000000000000284","article-title":"Safety and efficacy of an artificial tear containing 0.3% hyaluronic acid in the management of moderate-to-severe dry eye disease","volume":"43","author":"L\u00f3pez-de la Rosa","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ICL.0000000000000236","article-title":"Efficacy and safety of 0.2% hyaluronic acid in the management of dry eye disease","volume":"43","author":"Pinto-Fraga","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"10","key":"10.1016\/j.clae.2026.102647_b0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/ICO.0b013e318180e55c","article-title":"Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study","volume":"27","author":"Troiano","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/aos.15675","article-title":"A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review","volume":"102","author":"Hynnekleiv","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2026.102647_b0035","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00417-022-05880-7","article-title":"The effect of sodium hyaluronate on tear film stability in patients with dry eye syndrome after cataract surgery","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/11206721221096321","article-title":"Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease","volume":"33","author":"Calonge","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2026.102647_b0045","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms24032758","article-title":"A critical appraisal of the physicochemical properties and biological effects of artificial tear ingredients and formulations","volume":"24","author":"Weng","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/jcm10061289","article-title":"Categorization of marketed artificial tear formulations based on their ingredients: a rational approach for their use","volume":"10","author":"Kathuria","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.clae.2026.102647_b0055","doi-asserted-by":"crossref","first-page":"058","DOI":"10.23937\/2378-346X\/1410058","article-title":"A novel osmoprotectant tear substitute for the treatment of dry eye disease","volume":"3","author":"Giannaccare","year":"2016","journal-title":"Int J Ophthalmol Clin Res"},{"issue":"4","key":"10.1016\/j.clae.2026.102647_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1515\/bmc-2012-0001","article-title":"The role of hyperosmotic stress in inflammation and disease","volume":"3","author":"Brocker","year":"2012","journal-title":"Biomol Concepts"},{"issue":"3","key":"10.1016\/j.clae.2026.102647_b0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pharmaceutics10030137","article-title":"Effect of 5-Oxo-2-pyrrolidinecarboxylic acid (PCA) as a new topically applied agent for dry eye syndrome treatment","volume":"10","author":"Tampucci","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clae.2026.102647_b0070","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2147\/OPTH.S135550","article-title":"Investigating the potential benefits of a new artificial tear formulation combining two polymers","volume":"11","author":"Simmons","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.clae.2026.102647_b0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02713683.2014.957776","article-title":"Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress","volume":"40","author":"Hua","year":"2015","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2026.102647_b0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5935\/0004-2749.20190097","article-title":"Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review","volume":"82","author":"Ribeiro","year":"2019","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0095","doi-asserted-by":"crossref","first-page":"21835","DOI":"10.1038\/s41598-022-26327-3","article-title":"The efficacy of ocular surface assessment approaches in evaluating dry eye treatment with artificial tears","volume":"12","author":"Szczesna-Iskander","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0100","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1038\/s41598-017-08534-5","article-title":"Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis","volume":"7","author":"Ang","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.clae.2026.102647_b0105","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00417-023-06083-4","article-title":"Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials","volume":"261","author":"Sun","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0110","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3390\/ijerph18052383","article-title":"A meta-analysis of the efficacy of hyaluronic acid eye drops for the treatment of dry eye syndrome","volume":"18","author":"Yang","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.clae.2026.102647_b0120","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., (Eds). Cochrane handbook for systematic reviews of interventions. Hoboken: John Wiley & Sons; 2019.","DOI":"10.1002\/9781119536604"},{"issue":"2","key":"10.1016\/j.clae.2026.102647_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles\u2014continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clae.2026.102647_b0130","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2147\/OPTH.S256480","article-title":"Safety and efficacy of a preservative-free artificial tear containing carboxymethylcellulose and hyaluronic acid for dry eye disease: a randomized, controlled, multicenter 3-month study","volume":"14","author":"Aragona","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jfo.2011.07.017","article-title":"Vismed\/Hylovis Study Group. Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease","volume":"35","author":"Baeyens","year":"2012","journal-title":"J Fr Ophtalmol"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000117","article-title":"Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease","volume":"22","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"10.1016\/j.clae.2026.102647_b0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/02713683.2020.1849733","article-title":"Efficacy and safety of sodium hyaluronate\/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: a clinical trial","volume":"46","author":"Belalc\u00e1zar-Rey","year":"2021","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-004-1040-6","article-title":"Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis","volume":"243","author":"Brignole","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2026.102647_b0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bjo.83.10.1121","article-title":"Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w\/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome","volume":"83","author":"Condon","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0160","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10792-017-0693-1","article-title":"Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye","volume":"38","author":"Cui","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.clae.2026.102647_b0170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/OPTH.S161578","article-title":"Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis","volume":"12","author":"Gro\u00df","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0175","doi-asserted-by":"crossref","first-page":"12659","DOI":"10.1038\/s41598-019-49159-0","article-title":"Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery: a randomized clinical trial","volume":"9","author":"Jun","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.clae.2026.102647_b0180","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/eye.2012.166","article-title":"Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study","volume":"26","author":"Kamiya","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clae.2026.102647_b0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/OPTH.S489669","article-title":"A prospective, crossover, randomized, double-blind clinical study comparing the effectiveness and ocular comfort of 0.1% hyaluronic acid and 0.3% hyaluronic acid in patients with dry eye disease","volume":"19","author":"Kim","year":"2025","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0190","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2016.08.004","article-title":"A two-week, randomized, double-masked study to evaluate safety and efficacy of lubricin (150\u03bcg\/mL) eye drops versus sodium hyaluronate (HA) 0.18% eye drops (Vismed\u00ae) in patients with moderate dry eye disease","volume":"15","author":"Lambiase","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.clae.2026.102647_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0b013e3181e9adcc","article-title":"Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.clae.2026.102647_b0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ICL.0000000000001101","article-title":"Clinical efficacy of 2% rebamipide in patients with video display terminal-associated dry eye disease: a prospective, randomized","volume":"50","author":"Lee","year":"2024","journal-title":"Double-Blinded Study Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0210","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.31925\/farmacia.2024.5.18","article-title":"Therapeutic outcome of sodium hyaluronate eye drops combined with recombinant epidermal growth factor derivative eye drops on postoperative xerophthalmia","volume":"72","author":"Liu","year":"2024","journal-title":"Farmacia"},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0215","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.21873\/invivo.13397","article-title":"Combination therapy with diquafosol sodium and sodium hyaluronate in eyes with dry eye disease after small incision lenticule extraction","volume":"37","author":"Liu","year":"2023","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.clae.2026.102647_b0220","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.eye.6700169","article-title":"A randomised, crossover, multicentre study to compare the performance of 0.1% (w\/v) sodium hyaluronate with 1.4% (w\/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome","volume":"16","author":"McDonald","year":"2002","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.clae.2026.102647_b0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00417-014-2853-6","article-title":"Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops","volume":"253","author":"Macri","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12886-024-03620-5","article-title":"Effectiveness of cyclosporine nanoemulsion eye drops in patients with mild-to-moderate dry eyes: objective and subjective evaluation","volume":"24","author":"Moon","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clae.2026.102647_b0235","unstructured":"National Clinical Trial (NCT00938704). Study to compare the efficacy and safety of two non-preserved artificial tears for the treatment of dry eye signs and symptoms. Available from: https:\/\/clinicaltrials.gov\/show\/NCT00938704 2009 [accessed 14 June 2025]."},{"issue":"2","key":"10.1016\/j.clae.2026.102647_b0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000050842","article-title":"Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients","volume":"215","author":"Papa","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clae.2026.102647_b0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2015.12.002","article-title":"Clinical effects and safety of 3% diquafosol ophthalmic solution for patients with dry eye after cataract surgery: a randomized controlled trial","volume":"163","author":"Park","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2026.102647_b0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jop.2016.0086","article-title":"A Randomized multicenter study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye","volume":"33","author":"Park","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2026.102647_b0255","unstructured":"Ren W, Chen T, Dong W, Tong Q. Effects of sodium hyaluronate combined with rhEGF eye drops in patients with dry eye. Pak J Pharm Sci. 2021;34(6(Special)):2461-2465."},{"issue":"6","key":"10.1016\/j.clae.2026.102647_b0260","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5301\/ejo.5000830","article-title":"Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study","volume":"26","author":"Robert","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102647_b0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-7-5","article-title":"Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study","volume":"7","author":"Rolando","year":"2007","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2026.102647_b0270","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4103\/IJO.IJO_2666_22","article-title":"Comparing the efficacy of sodium hyaluronate eye drops and carboxymethylcellulose eye drops in treating mild to moderate dry eye disease","volume":"71","author":"Salim","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2026.102647_b0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ICO.0b013e3181b11648","article-title":"Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study","volume":"29","author":"Sanchez","year":"2010","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.clae.2026.102647_b0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4314\/tjpr.v23i1.15","article-title":"Efficacy of the combination of cyclosporine and sodium hyaluronate eye drops on dry eye syndrome","volume":"23","author":"Shen","year":"2024","journal-title":"Trop J Pharm Res"},{"issue":"10","key":"10.1016\/j.clae.2026.102647_b0285","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s40123-024-01015-9","article-title":"Evaluation of two artificial tears containing hyaluronic acid for post cataract surgery dry eye disease: a randomized controlled trial","volume":"13","author":"Sun","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"10.1016\/j.clae.2026.102647_b0290","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/OPX.0000000000002136","article-title":"Changes in corneal epithelial irregularity following treatment with artificial tears","volume":"101","author":"Tan","year":"2024","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2026.102647_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2013.11.017","article-title":"Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis","volume":"157","author":"Toda","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102647_b0300","doi-asserted-by":"crossref","unstructured":"Wang Y, Yuan J, Wen Y, Li S, Tian L, Jie Y. Clinical observation of esculin and digitalisglycosides eye drops with 0.3% sodium hyaluronate eye drops for dry eye disease: a randomized controlled trial. Sci Rep. 2025;15(1):5747. doi: 10.1038\/s41598-025-90074-4.","DOI":"10.1038\/s41598-025-90074-4"},{"issue":"4","key":"10.1016\/j.clae.2026.102647_b0305","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.21037\/apm-20-1453","article-title":"A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain. Ann","volume":"10","author":"Wu","year":"2021","journal-title":"Palliat Med"},{"issue":"10","key":"10.1016\/j.clae.2026.102647_b0310","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s10792-021-01897-9","article-title":"Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities","volume":"41","author":"Brar","year":"2021","journal-title":"Int Ophthalmol"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048426000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048426000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:40:43Z","timestamp":1788244843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048426000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1367048426000433"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2026.102647","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing hyaluronic acid therapy for dry eye disease: a systematic review, meta-analysis, and meta-regression by concentration and comparator type","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2026.102647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102647"}}